Shifting the Paradigm to Pragmatic Evidence Generation
Integrated evidence generation (IEG) is a framework for generating evidence to support regulatory decision-making in healthcare, automate real-world data collection and grow evergreening data networks that fuel a variety of needs.
› READ THE BLOGPOSTERS
Addressing Gaps in Real-World Data Sources through Automated Extraction of Psychiatric Comorbidities and Medication Side Effects from Clinical Notes
MAY 9, 2024
At ISPOR Annual 2024, Jessica Probst, MPH presented in the AI in HEOR poster tour on Addressing Gaps in Real-World Data Sources through Automated Extraction of Psychiatric Comorbidities and Medication Side Effects from Clinical Notes. This poster was also a Top 5% Finalist for the ISPOR 2024 Research Presentation Awards. View the full poster >>
Real-World Characterization and Management of Alopecia Areata Patients in the U.S.
MAY 16, 2023
View our poster on Real-World Characterization and Management of Alopecia Areata Patients in the U.S. Click to view!
EVENTS
ISPOR Europe 2024
JUL 18, 2024
Event: ISPOR Europe 2024 When: November 17-20, 2024 Where: Barcelona, Spain Booth #: 1207 Theater Presentation: Date: Monday November 18, 2024 Time: 11:45 am For additional information or to schedule a meeting with our experts, contact us at info@om1.com
The CNS Summit
JUL 18, 2024
Event: The CNS Summit When: October 10-13, 2024 Where: Everett, MA Booth #: TBD For additional information or to schedule a meeting with our experts, contact us at info@om1.com
EBOOKS
Real-World Analytics: A Complimentary Suite of Analytic Reports
JUL 15, 2024
A complimentary suite of analytic reports for understanding the reasons behind medication discontinuation, patient outcomes, and prescribing behaviors. Introduction to Real-World Analytics Reasons for Discontinuation Report Comparative Outcomes Report Prescriber Trends Report Meet our Experts View the ebook >>
Analyses & Insights from the OM1 Dermatology Data Network
JUL 15, 2024
Bringing new treatments to market and delivering more precise care is challenging enough. Finding the data to support your programs shouldn’t be. This ebook explores powerful insights, analyses, and use cases from OM1’s Dermatology Network: Dermatologic diseases are complex. Getting valuable insights shouldn’t be. OM1 Dermatology Datasets Psoriasis Psoriatic Arthritis Alopecia Areata Atopic Dermatitis Hidradenitis[…]
VIDEOS
PhenOM: AI Solutions
JUL 16, 2024
PhenOM® is an artificial intelligence (AI)-powered digital phenotyping platform trained using OM1’s repository of linked EMR, claims and other data covering more than 300 million patients. The richness of the source data lets these phenotypes capture many complex facets of the target patients’ journeys. View the video on YouTube >>
OM1 Aspen: Integrated Evidence Generation
JUL 16, 2024
OM1 Aspen leverages our proprietary data sourcing, processing and enrichment technologies, including electronic medical records harmonization, image management, advanced medical text processing and linkage, to deliver a more efficient, cost-effective and scalable approach to research. Tap into our networks or build new ones for automated evidence generation. Harness scientifically robust data from large and diverse[…]
NEWS & ARTICLES
How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
JUN 24, 2024
June 24, 2024 Pharma’s Almanac Read the full article >> Rich Gliklich, M.D., Chief Executive Officer and founder, OM1 One impactful way will be through platforms that enable data and study automation. In recent remarks, FDA Commissioner Dr. Robert Califf argued that there is tremendous opportunity to simplify and digitize data collection to create more pragmatic[…]
Panalgo and OM1 Expand Partnership to Offer OM1’s PremiOM Datasets in Panalgo’s IHD Analytics Platform
JUN 19, 2024
Cision June 18, 2024 Read the full press release >> Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, is announcing a new venture with partner OM1, a forefront leader in real-world evidence (RWE) insights generation, deep specialty data, and advanced AI healthcare technologies. This latest offering enables Panalgo to host OM1’s PremiOM enriched[…]
WHITE PAPERS
From Big Data to Measurable Outcomes: OBC
JUL 6, 2017
A heightened focus on value is driving efforts across health care to improve outcomes and reduce costs. For pharmaceutical companies, this focus translates into a shift away from traditional payment models to more outcomes-based, risk sharing agreements. In many ways, these agreements present the opportunity to better align interests across health care’s stakeholders. However, they[…]
Improving Performance under Bundled Care
NOV 5, 2016
The field of medicine is changing rapidly due to two major disruptions – the application of artificial intelligence, such as machine and deep learning and the shift from fee-for-service to value-based payment models. These innovations, which are occurring simultaneously, are fundamentally altering how data are used and how care is provided. To survive in this[…]
WEBINARS
Unveiling the Unseen: AI’s Role in Identifying Treatment-Resistant Depression
JUL 18, 2024
Thu, Aug 15, 2024 2:00 PM – 3:00 PM EDT Presenter: Carl Marci, MD, Chief Clinical Officer and Chief Psychiatrist and Managing Director of Mental Health and Neuroscience, OM1 Register >> Treatment-resistant depression (TRD) presents a formidable challenge for life sciences researchers, with its complex definition varying across clinical care, reimbursement, and regulatory contexts. This[…]
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
MAY 1, 2024
DATE: Thursday, May 23, 2024 TIME: 11:00 am EST PRESENTER: Joseph Zabinski, PhD REGISTER HERE >> In this webinar, Dr. Joseph Zabinski will discuss the digital phenotyping process and several concrete applications to demonstrate how AI can add value to analyses of the patient journey across the life sciences spectrum. Real-world data provide insight into[…]